Table 2.
Associations of COVID-19 with OSA severity and treatment
Suspected COVID-19 | COVID-19+ | Suspected COVID-19 | COVID-19+ | ||
---|---|---|---|---|---|
Frequency (percent) | Frequency (percent) | Adjusted OR (95% CI)* | Adjusted OR (95% CI)* | ||
AHI (5-15) | 43 | 7 (16.3) | 6 (14) | 1⁎⁎ | 1 ⁎⁎ |
AHI (15-30) | 60 | 18 (30) | 10 (16.7) | 1.81 (0.67-4.93) | 1.04 (0.40-2.69) |
AHI ≥30 | 172 | 30 (17.4) | 35 (20.3) | 1.57 (0.61-4.95) | 2.31 (0.87-5.55) |
Treatment for apnea | |||||
Yes | 81 | 26 (32.1) | 12 (14.8) | 1⁎⁎⁎ | 1 ⁎⁎⁎ |
No | 188 | 28 (14.9) | 38 (20.2) | 0.83 (0.39-1.75) | 2.43 (1.26-4.67) |
OR, odds ratio; AHI, apnea hypopnea index.
Adjusted odds ratio for age, sex, BMI, and pulmonary diseases.
In the multinominal logistic regression, healthy group (without COVID-19) and patients with AHI 5-15 were considered as reference groups.
In the multinominal logistic regression healthy group (without COVID-19) and patients with treatment are considered as reference groups.